These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35304924)

  • 1. Adamgammadex in patients to reverse a moderate rocuronium-induced neuromuscular block.
    Jiang YY; Zhang YJ; Zhu ZQ; Huang YD; Zhou DC; Liu JC; Li CY; Liu J; Liu B; Zhang WS
    Br J Clin Pharmacol; 2022 Aug; 88(8):3760-3770. PubMed ID: 35304924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block.
    Zhang Y; Jiang Y; Lei Q; Li C; Jin S; Wang Q; Huang Y; Li Y; Hong Y; Wang S; Lin H; Li H; Ou Y; Zou X; Sun Q; Guo Q; Chen Z; Min S; Qi Y; Jie Q; Liu J; Liu B; Zhang W
    Br J Anaesth; 2024 Jan; 132(1):45-52. PubMed ID: 38007377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
    Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
    Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J
    Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Efficacy and Safety of Adamgammadex with Sugammadex for Reversal of Rocuronium-Induced Neuromuscular Block: Results of a Phase II Clinical Trial.
    Jiang Y; Zhang Y; Zhu Z; Huang Y; Zhou D; Liu J; Li C; Chen X; Kang D; Wang S; Liu J; Liu B; Zhang W
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block. Comment on Br J Anaesth 2024; 132: 45-52.
    Miyazaki Y; Suzuki K; Sunaga H
    Br J Anaesth; 2024 Apr; 132(4):820-821. PubMed ID: 38296751
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety, tolerability, and pharmacokinetics of adamgammadex sodium, a novel agent to reverse the action of rocuronium and vecuronium, in healthy volunteers.
    Jiang Y; Zhang Y; Xiang S; Zhao W; Liu J; Zhang W
    Eur J Pharm Sci; 2020 Jan; 141():105134. PubMed ID: 31678425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of rocuronium induced neuromuscular block with sugammadex in patients under 2 years of age. A series of 280 cases.
    Ozmete O; Dardag E; Civi S
    Ann Ital Chir; 2023; 94():612-616. PubMed ID: 38131376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurarization with magnesium sulfate administered after two minutes sugammadex reversal: A randomized, double-blind, controlled trial.
    Germano-Filho PA; Cavalcanti IL; Micuci AJQR; Velarde LGC; de Boer HD; Verçosa N
    J Clin Anesth; 2023 Oct; 89():111186. PubMed ID: 37393856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
    Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
    Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of adamgammadex for reversing rocuronium-induced deep neuromuscular blockade: A multicenter, randomized, phase IIb study.
    Zhao Y; Chen S; Xie W; Zhang X; Chen G; Ji F; Wang D; Qi Y; Jie Q; Su D; Yu W
    Clin Transl Sci; 2024 Jan; 17(1):e13691. PubMed ID: 38266059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency estimation of sugammadex for the reversal of moderate rocuronium-induced neuromuscular block: a non-randomized dose-response study.
    Kitajima O; Yamamoto M; Takagi S; Suzuki T
    J Anesth; 2020 Jun; 34(3):348-351. PubMed ID: 32095883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency and Safety of the Selective Relaxant Binding Agent Adamgammadex Sodium for Reversing Rocuronium-Induced Deep Neuromuscular Block: A Single-Center, Open-Label, Dose-Finding, and Phase IIa Study.
    Zhao Y; Chen S; Huai X; Yu Z; Qi Y; Qing J; Yu W; Su D
    Front Med (Lausanne); 2021; 8():697395. PubMed ID: 34513870
    [No Abstract]   [Full Text] [Related]  

  • 19. Is adamgammadex the brother of sugammadex or the next generation of reversal agent?
    Hunter JM; Sneyd JR
    Br J Anaesth; 2024 Jan; 132(1):15-17. PubMed ID: 38171649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison Between the Adductor Pollicis Muscle Using TOF-Watch SX and the Abductor Digiti Minimi Muscle Using TetraGraph in Rocuronium-Induced Neuromuscular Block: A Prospective Observational Study.
    Iwasaki H; Yamamoto M; Sato H; Doshu-Kajiura A; Kitajima O; Takagi S; Luthe SK; Suzuki T
    Anesth Analg; 2022 Aug; 135(2):370-375. PubMed ID: 35061641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.